This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schieppati A et al. (2004) Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. The Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD004293.pub2. [doi:10.1002/14651858.CD004293.pub2]
Mathieson P (1998) Treating progressive and indolent MGN. QJM 91: 167
Mathieson PW (2000) Cyclosporin: nephro-protective as well as nephrotoxic? Clin Exp Immunol 121: 179–180
Cattran DC et al. (2001) Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int 59: 1484–1490
Ronco P and Debiec H (2006) Molecular dissection of target antigens and nephritogenic antibodies in membranous nephropathy: towards epitope-driven therapies. J Am Soc Nephrol 17: 1772–1774
Acknowledgements
The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Mathieson, P. Is low-dose ciclosporin an effective treatment for membranous nephropathy with nephrotic syndrome?. Nat Rev Nephrol 3, 190–191 (2007). https://doi.org/10.1038/ncpneph0436
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0436